News

Divide and Conquer: UCSF Cancer Team Finds Promise in Precision Medicine Approach to Osteosarcoma

Using a divide and conquer strategy, researchers from the University of California San Francisco have provided a road map for the development of a precision medicine approach to osteosarcoma, the most common bone cancer in children and young adults and an aggressive disease for which treatment has

Radiation Dose in CT Scans Varies Due to Scanners' Technical Settings

The amount of radiation that patients are exposed to from computed tomography (CT) scans varies widely between institutions and countries, and is largely due to differences in the technical settings of the scanning machines at each institution, according to an international study led by UC San

Landmark Mammography Study Highlights the Importance of Breast Cancer Screening

A landmark mammography study has found that women who receive annual breast cancer screenings will have a lower mortality rate and will benefit more from therapy upon diagnosis of breast cancer. The lead investigator on this study was László Tabár, MD. He and his team analyzed data from the Swedish

Faculty Ideas Inspire Record-Breaking Year for UCSF's Campaign

UCSF staffers distribute t-shirts at the campus launch event for UCSF: The Campaign in 2017. From left to right: Toshonna Ross, Peggy Huey, Krista Dow and Dresden Joswig. Photo by Elisabeth Fall In the year since announcing an ambitious, $5 billion fundraising campaign, UC San Francisco has seen

Prostate Cancer Disparities Greatest in Low-Risk Disease

Black men in the United States are known to suffer disproportionately from prostate cancer. Now, a new study investigating prostate cancer deaths by race has found that African American men have twice the chance of dying from low-risk prostate cancer than men of other racial and ethnic groups, even

Year in Review: 2018

Precision medicine, immunotherapy, and population health led the news at the UCSF Helen Diller Family Comprehensive Cancer Center in 2018. Whether through expediting drug discovery, tailoring genomic sequencing, or expanding palliative care, our UCSF cancer community remained committed to improving

Cancer Researchers ID 'Achilles Heel' of Drug-Resistant Tumors

UC San Francisco scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies. In the process, they devised a new two-pronged approach that yields an effective treatment for these cancers in the laboratory and holds tremendous promise for